Drugs / Q-Urol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04252625 Comparator | Nov 2022 → Dec 2023 | prostate adenocarcinoma | University of Utah | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Q-Urol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04252625 ↗ |